Neurocrine Biosciences (NBIX) Net Cash Flow (2010 - 2026)
Neurocrine Biosciences (NBIX) recorded Net Cash Flow of $64.4 million in Q2 2026, down 7.6% from $69.7 million a year earlier.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Net Cash Flow (2010 - 2026) Analysis & Trends
On a TTM basis, Neurocrine Biosciences' Net Cash Flow came in at $67.1 million as of Jun 30, 2026, down 45.9% year-over-year; for FY2025, it came in at $480 million.
- Annual Net Cash Flow has a five-year compound annual growth rate of 45.0% (FY2020 to FY2025).
- Across earlier years, Net Cash Flow came in at -$18.1 million in FY2024, -$11.9 million in FY2023, -$72 million in FY2022 and $153.7 million in FY2021 (+105.5%).
- Quarterly Net Cash Flow has ranged from -$446.5 million in Q1 2026 to $372.8 million in Q4 2025 over the past five years.
- Per Business Quant, the preceding three quarters came in at -$446.5 million (Q1 2026), $372.8 million (Q4 2025) and $76.4 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -1.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -2.82 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.53 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 757.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.62 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.95 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -4.43 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -722.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 652.90 Mn |
| 10 | Neurocrine Biosciences | 14.41 Bn | 10.11 Bn | 935.80 Mn | 64.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 64.40 Mn |
| Mar 31, 2026 | -446.50 Mn |
| Dec 31, 2025 | 372.80 Mn |
| Sep 30, 2025 | 76.40 Mn |
| Jun 30, 2025 | 69.70 Mn |
| Mar 31, 2025 | -38.90 Mn |
| Dec 31, 2024 | -115.80 Mn |
| Sep 30, 2024 | 209.10 Mn |
| Jun 30, 2024 | -256.60 Mn |
| Mar 31, 2024 | 145.20 Mn |
| Dec 31, 2023 | -42.90 Mn |
| Sep 30, 2023 | 133.50 Mn |
| Jun 30, 2023 | 56.60 Mn |
| Mar 31, 2023 | -159.10 Mn |
| Dec 31, 2022 | 52.00 Mn |
| Sep 30, 2022 | 48.90 Mn |
| Jun 30, 2022 | -106.90 Mn |
| Mar 31, 2022 | -66.00 Mn |
| Dec 31, 2021 | 29.70 Mn |
| Sep 30, 2021 | -56.90 Mn |
API Access
Neurocrine Biosciences Net Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-cash-flow&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-cash-flow", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-cash-flow&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();